THQM — Tchaikapharma High Quality Medicines AD Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Market Cap
BGN1.61bn
Enterprise Value
BGN1.62bn
Revenue
BGN53.27m

Annual balance sheet for Tchaikapharma High Quality Medicines AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.

	2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.046	0.057	0.142	0.073	0.14
Net Total Accounts Receivable
Net Total Receivables	60	57.5	58.8	60.2	62.2
Total Inventory
Prepaid Expenses
Total Current Assets	71	70.7	75.7	80.9	84.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	37.1	38.1	35.3	33.1	33.3
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	117	117	120	122	127
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17.1	15.7	15.6	15.3	14.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	20.2	18.6	18.3	17.5	16.7
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	97.1	98.8	102	105	110
Total Liabilities & Shareholders' Equity	117	117	120	122	127
Total Common Shares Outstanding